<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 16:51:03" record="26753" source="Espacenet">
	<entities>
		<entity ref="Patent26753" type="Patent">
			<semanticIdentifier>brcris::8c1efd221a071a99961e7e743ee0c1ec</semanticIdentifier>
			<semanticIdentifier>docdb::BR102014027786A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102014027786</semanticIdentifier>
			<semanticIdentifier>docdb::BR102014027786A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20141027786</semanticIdentifier>
			<semanticIdentifier>original::102014027786</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102014027786"/>
			<field name="identifier.lattes" value="2647529909397336"/>
			<field name="identifier.espacenet" value="102014027786"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="uso novos compostos com atividade antileishmania, sais farmaceutimente aceitáveis, composições framacêuticas contendo com os mesmos, e, processo para sua preparação."/>
			<field name="title.lattes" value="USO DE NOVOS COMPOSTOS (e)-3-(3,5-di-tert-butil-4-hidroxifenil)-1-(4-hidroxi-3-metoxifenil)prop-2-en-1-ona COM ATIVIDADE ANTILEISHMANIA, SAIS FARMACEUTICAMENTE ACEITÁVEIS, COMPOSIÇÕES FARMACÊUTICAS CONTENDO OS MESMOS, E, PROCESSOS PARA SUA PREPARAÇÃO"/>
			<field name="depositDate" value="2014-11-07"/>
			<field name="publicationDate" value="2016-05-24"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="BRUNA DOS SANTOS RODRIGUES"/>
			<field name="inventor" value="ERIC DE SOUZA GIL"/>
			<field name="inventor" value="LUCIANO MORAIS LIAO"/>
			<field name="inventor" value="MARINA CLARE VINAUD"/>
			<field name="inventor" value="MARIZE CAMPOS VALADARES BOZINIS"/>
			<field name="inventor" value="MARIZE CAMPOS VALADARES"/>
			<field name="inventor" value="RANGEL MAGALHAES LUZIN"/>
			<field name="inventor" value="RICARDO MANEGATTI"/>
			<field name="inventor" value="RICARDO MENEGATTI"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DE GOIAS"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K31/12AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="12AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61P33/02AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="33"/>
				<field name="subgroup" value="02AI"/>
			</field>
			<field name="abstract.espacenet" value="uso de novos compostos com atividade antileishmania, sais f armaceuticamente aceitáveis, composições farmacêuticas contendo os mesmos, e, processos para sua preparação. são descritos novos derivados do núcleo (e)-3-(3,5-di-tert-butil-4-hidroxifenil)- 1-( 4-b-a-3-metoxifenil)prop-2-en-1-ona, que atuam como antileishmaniais com ação em modelos in vitro de cultura de l. (l.) amazonensis (iflaibr/1967 /ph8) promastigotas, sendo portanto úteis no tratamento da leishmaniose, incluindo: em mamíferos, preferencialmente humanos; também são descritas composições farmacêuticas e sais farmaceuticamente aceitáveis contendo os referidos compostos e processos para sua preparação, bem como ferramenta farmacológica."/>
			<field name="originatesFrom" value="56012834"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102014027786"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102014027786"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102014027786"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20141027786"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="102014027786"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person18522" type="Person">
			<semanticIdentifier>lattes::2647529909397336</semanticIdentifier>
			<field name="identifier.lattes" value="2647529909397336"/>
			<field name="name" value="Luciano Morais Liao"/>
		</entity>
		<entity ref="OrgUnit14483" type="OrgUnit">
			<semanticIdentifier>brcris::0a240c63278feffcbeb0015483982a39</semanticIdentifier>
			<field name="name" value="UNIVERSIDADE FEDERAL DE GOIAS"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent26753" toEntityRef="Person18522" type="Inventor"/>
		<relation fromEntityRef="Patent26753" toEntityRef="OrgUnit14483" type="Applicant"/>
	</relations>
</entity-relation-data>
